Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021
Top Cited Papers
- 29 January 2021
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in Mmwr. Morbidity and Mortality Weekly Report
- Vol. 70 (4), 125-129
- https://doi.org/10.15585/mmwr.mm7004e1
Abstract
This report describes cases of anaphylaxis after administration of first doses of the Moderna COVID-19 vaccine during December 21, 2020–January 10, 2021.Keywords
This publication has 8 references indexed in Scilit:
- Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020Mmwr-Morbidity and Mortality Weekly Report, 2021
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020Mmwr. Morbidity and Mortality Weekly Report, 2021
- Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity — United States, January 26–October 3, 2020Mmwr. Morbidity and Mortality Weekly Report, 2020
- Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016Journal of Allergy and Clinical Immunology, 2019
- Vaccine-associated hypersensitivityJournal of Allergy and Clinical Immunology, 2018
- Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)Vaccine, 2015
- Anaphylaxis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety dataVaccine, 2007
- The reporting sensitivities of two passive surveillance systems for vaccine adverse events.American Journal of Public Health, 1995